Does anyone know if we have we completed the first two agenda items of 2010 yet?
"Now that we've completed the purchase of the BioHarp, the company has a clear path it will take to deliver this cutting-edge product to the healthcare community globally. Our intentions are to do the following:
1. Finalize the end product design relating to the device and software. This has already been agreed upon by management and we will look to have the finished product very shortly to begin sales to the veterinary, equine, and horticulture sectors.
2. Secure our manufacturing contracts so we can meet our anticipated needs of 20-30,000 units per month for 2010. (This number could rise dramatically based on our current contract conversations with several health organizations globally.)
Market Data 
Markets 
AI
